A strategy for oligonucleotide microarray probe reduction
Antipova, A. A., P. Tamayo, and T. R. Golub. 2002. “A Strategy for Oligonucleotide Microarray Probe Reduction”. Genome Biol 3: RESEARCH0073.
Search
Search results
744 results found
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification
Armstrong, S. A., A. L. Kung, M. E. Mabon, L. B. Silverman, R. W. Stam, M. L. Den Boer, R. Pieters, et al. 2003. “Inhibition of FLT3 in MLL. Validation of a Therapeutic Target Identified by Gene Expression Based Classification”. Cancer Cell 3: 173-83.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., G. Caponigro, N. Stransky, K. Venkatesan, A. A. Margolin, S. Kim, C. J. Wilson, et al. 2012. “The Cancer Cell Line Encyclopedia Enables Predictive Modelling of Anticancer Drug Sensitivity”. Nature 483: 603-7.
Stem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., K. Takenaka, E. R. Lechman, L. Waldron, B. Nilsson, P. Galen, K. H. Metzeler, et al. 2011. “Stem Cell Gene Expression Programs Influence Clinical Outcome in Human Leukemia”. Nat Med 17: 1086-93.
Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)
Fang, C., B. D’Souza, C. F. Thompson, M. C. Clifton, J. W. Fairman, B. Fulroth, A. Leed, et al. 2014. “Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)”. ACS Med Chem Lett 5: 1308-12.
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Geller, L. T., M. Barzily-Rokni, T. Danino, O. H. Jonas, N. Shental, D. Nejman, N. Gavert, et al. 2017. “Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine”. Science 357: 1156-60.
Toward a functional taxonomy of cancer
Golub, T. R. 2004. “Toward a Functional Taxonomy of Cancer”. Cancer Cell 6: 107-8.
Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. “Fusion of PDGF Receptor Beta to a Novel Ets-Like Gene, Tel, in Chronic Myelomonocytic Leukemia With T(5;12) Chromosomal Translocation”. Cell 77: 307-16.
The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms
Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1997. “The TEL Gene Contributes to the Pathogenesis of Myeloid and Lymphoid Leukemias by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 220: 67-79.
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
Hieronymus, H., J. Lamb, K. N. Ross, X. P. Peng, C. Clement, A. Rodina, M. Nieto, et al. 2006. “Gene Expression Signature-Based Chemical Genomic Prediction Identifies a Novel Class of HSP90 Pathway Modulators”. Cancer Cell 10: 321-30.